WCM Investment Management LLC Has $287.57 Million Stock Holdings in STERIS plc $STE

WCM Investment Management LLC lowered its stake in STERIS plc (NYSE:STE) by 44.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,171,994 shares of the medical equipment provider’s stock after selling 927,121 shares during the quarter. WCM Investment Management LLC owned approximately 1.19% of STERIS worth $287,572,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Norges Bank bought a new position in STERIS in the second quarter valued at approximately $289,132,000. Orbis Allan Gray Ltd boosted its holdings in shares of STERIS by 36.0% in the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock valued at $504,486,000 after buying an additional 556,088 shares during the last quarter. Thrivent Financial for Lutherans boosted its holdings in shares of STERIS by 246.4% in the 3rd quarter. Thrivent Financial for Lutherans now owns 553,834 shares of the medical equipment provider’s stock valued at $137,041,000 after buying an additional 393,970 shares during the last quarter. Invesco Ltd. grew its stake in shares of STERIS by 32.2% in the second quarter. Invesco Ltd. now owns 1,220,699 shares of the medical equipment provider’s stock valued at $293,236,000 after buying an additional 297,076 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its holdings in STERIS by 305.9% during the third quarter. Assenagon Asset Management S.A. now owns 330,907 shares of the medical equipment provider’s stock worth $81,880,000 after buying an additional 249,386 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In other news, VP John Adam Zangerle sold 15,000 shares of the stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the transaction, the vice president owned 33,669 shares in the company, valued at approximately $8,926,998.66. This trade represents a 30.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Renato Tamaro sold 5,036 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total value of $1,297,021.80. Following the completion of the sale, the vice president owned 5,695 shares of the company’s stock, valued at $1,466,747.25. This trade represents a 46.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 25,044 shares of company stock valued at $6,586,218 in the last three months. 1.07% of the stock is currently owned by company insiders.

STERIS Stock Up 0.9%

STE stock opened at $264.85 on Tuesday. The company has a current ratio of 2.37, a quick ratio of 1.63 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $25.99 billion, a PE ratio of 38.05 and a beta of 1.03. STERIS plc has a 1-year low of $204.90 and a 1-year high of $269.44. The business’s 50 day simple moving average is $259.33 and its 200 day simple moving average is $249.18.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter last year, the firm posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Tuesday, February 17th will be paid a $0.63 dividend. The ex-dividend date is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s dividend payout ratio is 36.21%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Six equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.